These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis. Pak CY; Peterson R; Sakhaee K; Fuller C; Preminger G; Reisch J Am J Med; 1985 Sep; 79(3):284-8. PubMed ID: 4036979 [TBL] [Abstract][Full Text] [Related]
25. On the relation between citrate and calcium in normal and stone-former subjects. Conte A; Roca P; Gianotti M; Grases F Int Urol Nephrol; 1990; 22(1):7-12. PubMed ID: 2380005 [TBL] [Abstract][Full Text] [Related]
26. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate. Pak CY; Fuller C Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503 [TBL] [Abstract][Full Text] [Related]
27. Dietary management of hypocitraturia in children with urolithiasis: results from a systematic review. Castellani D; Giulioni C; De Stefano V; Brocca C; Fuligni D; Galosi AB; Teoh JY; Sarica K; Gauhar V World J Urol; 2023 May; 41(5):1243-1250. PubMed ID: 36645461 [TBL] [Abstract][Full Text] [Related]
28. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones? Laube N; Jansen B; Hesse A Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124 [TBL] [Abstract][Full Text] [Related]
29. Clinical significance of hypocitraturia in kidney stone patients. Matsushita K; Tanikawa K; Masuda A; Matsuzaki S Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1253-7. PubMed ID: 8139138 [TBL] [Abstract][Full Text] [Related]
30. [Indication of the urinary citrate levels in idiopathic renal calculosis]. Jaeger P; Portmann L; Jacquet AF; Burckhardt P Schweiz Med Wochenschr; 1986 Mar; 116(12):371-3. PubMed ID: 3961456 [TBL] [Abstract][Full Text] [Related]
31. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. Soygür T; Akbay A; Küpeli S J Endourol; 2002 Apr; 16(3):149-52. PubMed ID: 12028622 [TBL] [Abstract][Full Text] [Related]
35. Citrate in the management of urolithiasis. Pattaras JG; Moore RG J Endourol; 1999 Nov; 13(9):687-92. PubMed ID: 10608522 [TBL] [Abstract][Full Text] [Related]
36. Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis. Hosking DH; Wilson JW; Liedtke RR; Smith LH; Wilson DM J Lab Clin Med; 1985 Dec; 106(6):682-9. PubMed ID: 4067380 [TBL] [Abstract][Full Text] [Related]
37. Urinary risk factors for recurrent calcium stone formation in Thai stone formers. Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123 [TBL] [Abstract][Full Text] [Related]
38. Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium sodium citrate administered as short-, medium- and long-term to male stone patients. Herrmann U; Schwille PO; Schwarzlaender H; Berger I; Hoffmann G Urol Res; 1992; 20(5):347-53. PubMed ID: 1455567 [TBL] [Abstract][Full Text] [Related]
39. Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy. Lojanapiwat B; Tanthanuch M; Pripathanont C; Ratchanon S; Srinualnad S; Taweemonkongsap T; Kanyok S; Lammongkolkul S Int Braz J Urol; 2011; 37(5):611-6. PubMed ID: 22099273 [TBL] [Abstract][Full Text] [Related]